Clinical Trial Update: Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing oral lactoferrin as a safe antiviral and immunoregulatory treatment for COVID-19 and related coronavirus infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease
• Middle East Respiratory Syndrome
• Respiratory Distress Syndrome

Drugs mentioned

• Lactoferrin (lactoferrin)

Snippet

Sponsor: National Research Centre, Egypt | Conditions: Corona Virus Infection, Middle East Respiratory Syndrome (MERS) | Phase 2 | Status: UNKNOWN